COVID-19: New Technology to Disinfect Maharashtra Hospitals under “NIDHI PRAYAS” Programme

A new technology has been adopted by the Maharashtra hospitals in the fight of COVID-19 fight. The technology was developed by a Pune based Start Up.

What is the product?

The product developed is a Negative Ion Generator. It has been named “Scitech Airon”. It helps to control bacteria, virus and fungal infections. The product disinfects areas that were exposed to infections thereby it ensures well being of doctors, nurses and staffs in the hospital. The product is highly useful in quarantine facilities. The Department of Science and Technology has released Rs 1 crore to manufacture the product in a larger scale. Around 1,000 of them are to be produced soon.

The technology was developed under “NIDHI PRAYAS” programme of Department of Science and Technology.


The Scitech Airon machine creates negatively charged ions. These ions form clusters around viruses, bacteria and other airborne molds. They then render them inactive through chemical reactions by creating Hydroxyl radicals (OH) groups. Apart from pathogens, the machine also decomposes harmful pollutants such as Carbon Monoxide, Nitrogen dioxide, etc.


There is lack of support in the early stages of prototyping in the country/ This causes many innovators to lose interest in the early stages. PRAYAS is Promoting and Accelerating Young and Aspiring technology entrepreneurs. It is one of the 9 programmes launched to turn the ideas of young innovators into proof of concepts.

Get these updates on Current Affairs Today Android App

WHO criticizes India over issues faced by Migrants during Lock Down

On March 30, 2020, the World Health Organization condemned countries including India for not taking actions to address the concerns of daily workers and migrant workers.


The organization had also condemned certain states in India like Bihar and Rajasthan for suspending their routine immunization programmes. Also, the closure of outpatient departments in government hospitals especially in AIIMS was of great concern to the organization.

WHO on Anti-Malarial Drug

Only India and USA are currently using the Anti-Malarial Drug called Hydroxychloroquine on a larger scale. The drugs are prescribed for asymptomatic persons that are in close contact with the COVID-19 patients. India has also banned the export of the drug adopting wider usage.

However, WHO believes that the safety of the drug to use it against COVID-19 is still not confirmed. Small observation studies show that the drug shortens illness caused by the virus.


The WHO recommends balanced approach in dealing with the virus. The organization recommends the approach of United Kingdom of using 20,000 retired health workers. Also, it calls upon the companies to talk to the companies to increase their production.

Get these updates on Current Affairs Today Android App